ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Federal Regs Prohibit RFP Budget Releases

February 21, 1975

Interview with FDA’s Richard Pazdur

October 30, 2009

ACCC Seeking Line Item, $21 Million for CCPs; Results Of Evaluation Released

June 5, 1987

Peters Replaced As Director Of Karmanos Cancer Center.

December 1, 2000

CTEP Publishes Final Version of Plan for Assigning Intellectual Property Rights On Correlative Research

April 8, 2011

NCI Advisory Group, Other Cancer Meetings

June 2, 1989